QuantumPharm, Inc. Statistics
Want to see HK:2228 full AI Analyst Report?
QuantumPharm, Inc. (2228) Stock Statistics & Valuation Metrics
Total Valuation
QuantumPharm, Inc. has a market cap or net worth of HKD 26.03B. The enterprise value is HKD 24.98B.
- Market Cap
- HKD 26.03B
- Enterprise Value
- HKD 24.98B
Share Statistics
QuantumPharm, Inc. has 4,296,818,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,296,818,400
- Owned by Insiders
- ―
- Owned by Institutions
- 9.19%
Financial Efficiency
QuantumPharm, Inc.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is -4.98%.
- Return on Equity (ROE)
- 0.01
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- -4.98%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 623.49K
- Profits Per Employee
- 96.13K
- Employee Count
- 1,254
- Asset Turnover
- 0.08
- Inventory Turnover
- 1.86
Valuation Ratios
The current PE Ratio of QuantumPharm, Inc. is -96.86. QuantumPharm, Inc.’s PEG ratio is 0.19.
- PE Ratio
- -96.86
- PS Ratio
- 32.04
- PB Ratio
- 2.26
- Price to FCF
- -59.67
- Price to Operating Cash Flow
- -72.82
- PEG Ratio
- 0.19
Income Statement
In the last 12 months, QuantumPharm, Inc. had revenue of 781.85M and earned 120.54M in profits. Earnings per share was 0.03.
- Revenue
- 781.85M
- Gross Profit
- 544.71M
- Operating Income
- -496.50M
- Pretax Income
- 131.85M
- Net Income
- 120.54M
- EBITDA
- 253.59M
- Earnings Per Share (EPS)
- 0.03
Cash Flow
In the last 12 months, operating cash flow was -279.77M and capital expenditures -79.44M, giving a free cash flow of -359.21M billion.
- Operating Cash Flow
- -279.77M
- Free Cash Flow
- -359.21M
- Free Cash Flow per Share
- -0.09
Dividends & Yields
QuantumPharm, Inc. pays an annual dividend of HKD 0.01, resulting in a dividend yield of ―
- Dividend Per Share
- HKD 0.01
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.68%
- Earnings Yield
- -1.02%
Stock Price Statistics
- Beta
- 1.70
- 52-Week Price Change
- -49.09%
- 50-Day Moving Average
- 6.90
- 200-Day Moving Average
- 8.16
- Relative Strength Index (RSI)
- 38.85
- Average Volume (3m)
- 54.44M
Important Dates
QuantumPharm, Inc. upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 19, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- Jun 13, 2016
Financial Position
QuantumPharm, Inc. as a current ratio of 14.77, with Debt / Equity ratio of 4.72%
- Current Ratio
- 14.77
- Quick Ratio
- 14.52
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -8.47
- Interest Coverage Ratio
- -54.40
Taxes
In the past 12 months, QuantumPharm, Inc. has paid 758.84K in taxes.
- Income Tax
- 758.84K
- Effective Tax Rate
- 0.01
Enterprise Valuation
QuantumPharm, Inc. EV to EBITDA ratio is -79.72, with an EV/FCF ratio of -60.97.
- EV to Sales
- 32.74
- EV to EBITDA
- -79.72
- EV to Free Cash Flow
- -60.97
- EV to Operating Cash Flow
- -78.29
Balance Sheet
QuantumPharm, Inc. has HKD 8.67B in cash and marketable securities with HKD 3.12B in debt, giving a net cash position of HKD 5.55B billion.
- Cash & Marketable Securities
- HKD 8.67B
- Total Debt
- HKD 3.12B
- Net Cash
- HKD 5.55B
- Net Cash Per Share
- HKD 1.29
- Tangible Book Value Per Share
- HKD 2.17
Margins
Gross margin is 51.52%, with operating margin of -129.13%, and net profit margin of -31.12%.
- Gross Margin
- 51.52%
- Operating Margin
- -129.13%
- Pretax Margin
- -24.29%
- Net Profit Margin
- -31.12%
- EBITDA Margin
- -41.07%
- EBIT Margin
- -49.82%
Analyst Forecast
The average price target for QuantumPharm, Inc. is HKD 9.39, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- HKD 9.39
- Price Target Upside
- 59.97% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 3.85%
- EPS Growth Forecast
- 6.86%
Scores
- Smart Score
- 1
- AI Score
- 45
